These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 443593)

  • 1. Cardiac function and hemodynamic parameters after pentaerythritol tetranitrate: assessment by a noninvasive radionuclide technique.
    Winsor D; Winsor T
    Angiology; 1979 Apr; 30(4):266-75. PubMed ID: 443593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac function and hemodynamic parameters after pentaerythritol tetranitrate. Assessment by new noninvasive radionuclide technique.
    Winsor T
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2465-9. PubMed ID: 7422536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained beneficial effects of oral pentaerythritol tetranitrate on ventricular function in chronic congestive heart failure.
    Shah PK; Shellock FG; Berman DS; Rubin SA; Singh BN; Swan HJ
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2447-50. PubMed ID: 7422534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The hemodynamic profile of pentaerythrityl tetranitrate].
    Engelmann L; Gottschild D
    Z Gesamte Inn Med; 1981 Apr; 36(7):244-6. PubMed ID: 7281826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained benefits or oral pentaerythritol tetranitrate on ventricular function in chronic congestive heart failure.
    Shellock FG; Shah PK; Berman DS; Rubin SA; Singh BN; Swan HJ
    Clin Pharmacol Ther; 1980 Oct; 28(4):436-40. PubMed ID: 7408403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term nitrate therapy in coronary heart disease--loss of effect by developing tolerance].
    Dück KD; Richard F
    Z Gesamte Inn Med; 1990 Dec; 45(24):736-41. PubMed ID: 2129317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pulmonary artery pressure measurement for assessment of bioavailability of isosorbide dinitrate and pentaerythritol tetranitrate (author's transl)].
    Gaul G; Aldor E
    Wien Med Wochenschr; 1980 Jan; 130(1):21-5. PubMed ID: 6994369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of three oral nitrate derivatives. A hemodynamic assessment in 10 patients with chronic heart failure (author's transl)].
    Bory M; Clavier P; Arnoux F; Djiane P; Egre A; Serradimigni A
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2437-42. PubMed ID: 6775296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic effects of a nitrate coronary vasodilator on cardiac perfusion and function, measured semiquantitatively.
    Winsor DW; Winsor T; Krohn BG; Bernett JR
    Angiology; 1982 Sep; 33(9):617-24. PubMed ID: 7125298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of combination therapy of pentalong (PETN) with obsidan (propranolol) in patients with coronary insufficiency].
    Gruber G; Hambsch K
    Z Arztl Fortbild (Jena); 1977 Feb; 71(4):167-71. PubMed ID: 868090
    [No Abstract]   [Full Text] [Related]  

  • 11. [Nitroderivatives. Novelty on old drugs].
    Campa PP
    Ann Ital Med Int; 1987; 2(3):236-41. PubMed ID: 3152793
    [No Abstract]   [Full Text] [Related]  

  • 12. [Efficacy of using vasodilating preparations in latent heart failure in patients with chronic ischemic heart disease].
    Volkov VS; Bratoliubov VP
    Kardiologiia; 1984 Aug; 24(8):89-92. PubMed ID: 6436573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-acting nitrates in the treatment of angina pectoris.
    Reichek N
    JAMA; 1976 Sep; 236(12):1399-402. PubMed ID: 822177
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of pentaerythritol tetranitrate pretreatment on experimental coronary occlusion.
    Meester WD; Van Harn GL
    Am Heart J; 1974 Sep; 88(3):330-7. PubMed ID: 4854772
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of oral pentaerythritol tetranitrate in cardiac failure and angina pectoris. Assessment by hemodynamic measurement and exercise capacity.
    Amsterdam EA; Lee G; Awan NA; Low R; Mason DT
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2443-6. PubMed ID: 7422533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug treatment of chronic coronary disease].
    Halawa B
    Wiad Lek; 1980 Jan; 33(2):107-11. PubMed ID: 6768197
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical study of a prolonged-action coronary vasodilator agent: pentaerythritol tetranitrate].
    Warembourg H; Théry C
    Lille Med; 1966; 11(6):742-5. PubMed ID: 5942195
    [No Abstract]   [Full Text] [Related]  

  • 18. Pentaerythritol Tetranitrate Targeting Myocardial Reactive Oxygen Species Production Improves Left Ventricular Remodeling and Function in Rats With Ischemic Heart Failure.
    Fraccarollo D; Galuppo P; Neuser J; Bauersachs J; Widder JD
    Hypertension; 2015 Nov; 66(5):978-87. PubMed ID: 26351025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Atherosclerosis progression and standard in coronary disease. Nitrate with special talents: PETN (pentaerythritol tetranitrate) is vasoprotective].
    MMW Fortschr Med; 2002 Nov; 144(45):51. PubMed ID: 12534064
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of coronary insufficiency with a combination of 2 nitro-derivatives. Controlled pluricentric clinical trial].
    Di Prisco AU; Vaccari GL; Soro A; Mora A
    Minerva Med; 1975 Feb; 66(12):551-61. PubMed ID: 1113905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.